Avoro Capital Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567M | Sell |
|
|||||
|
2025
Q1 | $670M | Sell |
|
|||||
|
2024
Q4 | $626M | Hold |
|
|||||
|
2024
Q3 | $431M | Sell |
|
|||||
|
2024
Q2 | $576M | Buy |
|
|||||
|
2024
Q1 | $519M | Buy |
|
|||||
|
2023
Q4 | $437M | Buy |
|
|||||
|
2023
Q3 | $227M | Buy |
|
|||||
|
2023
Q2 | $350M | Sell |
|
|||||
|
2023
Q1 | $404M | Buy |
|
|||||
|
2022
Q4 | $482M | Buy |
|
|||||
|
2022
Q3 | $99.8M | Hold |
|
|||||
|
2022
Q2 | $110M | Buy |
|
|||||
|
2022
Q1 | $140M | Hold |
|
|||||
|
2021
Q4 | $121M | Hold |
|
|||||
|
2021
Q3 | $114M | Hold |
|
|||||
|
2021
Q2 | $139M | Hold |
|
|||||
|
2021
Q1 | $167M | Buy |
|
|||||
|
2020
Q4 | $136M | Buy |
|
|||||
|
2020
Q3 | $106M | Buy |
|
|||||
|
2020
Q2 | $39.6M | Buy |
|
|||||
|
2020
Q1 | $23.3M | Hold |
|
|||||
|
2019
Q4 | $31.8M | Sell |
|
|||||
|
2019
Q3 | $31M | Hold |
|
|||||
|
2019
Q2 | $37.7M | Buy |
|
|||||
|
2019
Q1 | $38.8M | Buy |
|
|||||
|
2018
Q4 | $25.4M | Sell |
|
|||||
|
2018
Q3 | $99.1M | Sell |
|
|||||
|
2018
Q2 | $137M | Buy |
|